Despite Doubters, Moderna Raises $500 Million, Is Now Worth $7 Billion

February 02, 2018 | Moderna Therapeutics, a biotechnology firm that is developing drugs that work on a genetic messaging system that is essentially to all living cells, has raised $500 million from a group of new and current investors. Forbes